<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title><![CDATA[Therapeutic Drug Monitoring (TDM)]]></title>
    <link>https://www.leadingmarketresearch.com/medical-devices-in-vitro-diagnostics/in-vitro-diagnostics/clinical-chemistry/therapeutic-drug-monitoring</link>
    <description><![CDATA[Therapeutic Drug Monitoring (TDM)]]></description>
    <pubDate>Tue, 12 May 2026 15:13:51 +0000</pubDate>
    <generator>Zend_Feed</generator>
    <docs>http://blogs.law.harvard.edu/tech/rss</docs>
    <item>
      <title><![CDATA[Europe Therapeutic Drug Monitoring (TDM) Market Assessment for 28 Assays in 38 Countries--Supplier Shares, Volume and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation, Opportunities]]></title>
      <link>https://www.leadingmarketresearch.com/europe-therapeutic-drug-monitoring-market</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p>This unique report from LeadingMarketResearch.com provides information and analysis <b>not available from any other published source</b>.</p><p>The report is available by country, section, and can be customized to specific information needs and budget.</p><p>This new report from LeadingMarketResearch provides a comprehensive analysis of the Europe therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.</p><p>The report provides test volume and sales forecasts by country and market segment for the following assays:</p><p><b>Amikacin, Apixaban, Argatroban, Betrixaban, Carbamazepine, Cyclosporin, Dabigatran, Digoxin, Edoxaban, Everolimus, Fluindione, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Rivaroxaban, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin, and Warfarin</b>.</p><p>During the next five years, the TDM market will undergo significant transformation. These change...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-228980"><span class="price">$1,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 13 Jun 2023 10:36:10 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[LatAm Therapeutic Drug Monitoring (TDM) Market Assessment for 28 Assays in 22 Countries--Supplier Shares, Volume and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities]]></title>
      <link>https://www.leadingmarketresearch.com/latam-therapeutic-drug-monitoring-market</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p>This unique report from LeadingMarketResearch.com provides information and analysis <b>not available from any other published source</b>.</p><p>The report is available by country, section, and can be customized to specific information needs and budget.</p><p>This new report from LeadingMarketResearch provides a comprehensive analysis of the Latin America therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.</p><p>The report provides test volume and sales forecasts by country and market segment for the following assays:</p><p><b>Amikacin, Apixaban, Argatroban, Betrixaban, Carbamazepine, Cyclosporin, Dabigatran, Digoxin, Edoxaban, Everolimus, Fluindione, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Rivaroxaban, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin, and Warfarin</b>.</p><p>During the next five years, the TDM market will undergo significant transformation. These...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-228981"><span class="price">$1,250.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 13 Jun 2023 10:36:10 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[2023 Global Therapeutic Drug Monitoring (TDM) Market Assessment for 28 Assays in US, Europe, Japan--2022 Supplier Shares and 2022-2027 Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation, Opportunities]]></title>
      <link>https://www.leadingmarketresearch.com/global-therapeutic-drug-monitoring-market</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p>This unique report from LeadingMarketResearch.com provides information and analysis <b>not available from any other published source</b>.</p><p>The report is available by section, and can be customized to specific information needs and budget.</p><p>This new report provides analysis of the global therapeutic drug monitoring testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.</p><p>The report provides test volume and sales forecasts by country and market segment for the following assays:</p><p><b>Amikacin, Apixaban, Argatroban, Betrixaban, Carbamazepine, Cyclosporin, Dabigatran, Digoxin, Edoxaban, Everolimus, Fluindione, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Rivaroxaban, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin, and Warfarin</b>.</p><p>During the next decade, the TDM market will undergo significant transformation. These changes will be caused by convergence of ne...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-228984"><span class="price">$2,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 13 Jun 2023 10:36:10 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Africa Therapeutic Drug Monitoring (TDM) Market Assessment for 28 Assays in 7 Countries--Supplier Shares and Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities]]></title>
      <link>https://www.leadingmarketresearch.com/africa-therapeutic-drug-monitoring-market</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p>This unique report from LeadingMarketResearch.com provides information and analysis <b>not available from any other published source</b>.</p><p>The report is available by country, section, and can be customized to specific information needs and budget.</p><p>This new report from LeadingMarketResearch provides a comprehensive analysis of the Africa therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.</p><p>The report provides test volume and sales forecasts by country and market segment for the following assays:</p><p><b>Amikacin, Apixaban, Argatroban, Betrixaban, Carbamazepine, Cyclosporin, Dabigatran, Digoxin, Edoxaban, Everolimus, Fluindione, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Rivaroxaban, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin, and Warfarin</b>.</p><p>During the next five years, the TDM market will undergo significant transformation. These change...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-228978"><span class="price">$1,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 13 Jun 2023 10:36:10 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Sweden Therapeutic Drug Monitoring (TDM) Market Assessment for 28 Assays--Supplier Shares and Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers]]></title>
      <link>https://www.leadingmarketresearch.com/sweden-therapeutic-drug-monitoring-market</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p>This unique report from LeadingMarketResearch.com provides information and analysis <b>not available from any other published source</b>.</p><p>The report is available by section, and can be customized to specific information needs and budget.</p><p>This new report from LeadingMarketResearch.com provides a comprehensive analysis of the therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.</p><p>The report provides test volume and sales forecasts by market segment for the following assays:</p><p><b>Amikacin, Apixaban, Argatroban, Betrixaban, Carbamazepine, Cyclosporin, Dabigatran, Digoxin, Edoxaban, Everolimus, Fluindione, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Rivaroxaban, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin, and Warfarin</b>.</p><p>During the next five years, the TDM market will undergo significant transformation. These changes will be caused by conv...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-229074"><span class="price">$650.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 13 Jun 2023 10:36:10 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Bulgaria Therapeutic Drug Monitoring (TDM) Market Assessment for 28 Assays--Supplier Shares and Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers]]></title>
      <link>https://www.leadingmarketresearch.com/bulgaria-therapeutic-drug-monitoring-market</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p>This unique report from LeadingMarketResearch.com provides information and analysis <b>not available from any other published source</b>.</p><p>The report is available by section, and can be customized to specific information needs and budget.</p><p>This new report from LeadingMarketResearch.com provides a comprehensive analysis of the therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.</p><p>The report provides test volume and sales forecasts by market segment for the following assays:</p><p><b>Amikacin, Apixaban, Argatroban, Betrixaban, Carbamazepine, Cyclosporin, Dabigatran, Digoxin, Edoxaban, Everolimus, Fluindione, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Rivaroxaban, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin, and Warfarin</b>.</p><p>During the next five years, the TDM market will undergo significant transformation. These changes will be caused by conv...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-229004"><span class="price">$650.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 13 Jun 2023 10:36:10 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Japan Therapeutic Drug Monitoring (TDM) Market Assessment for 28 Assays--Supplier Shares and Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers]]></title>
      <link>https://www.leadingmarketresearch.com/japan-therapeutic-drug-monitoring-market</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p>This unique report from LeadingMarketResearch.com provides information and analysis <b>not available from any other published source</b>.</p><p>The report is available by section, and can be customized to specific information needs and budget.</p><p>This new report from LeadingMarketResearch.com provides a comprehensive analysis of the French therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.</p><p>The report provides test volume and sales forecasts by market segment for the following assays:</p><p><b>Amikacin, Apixaban, Argatroban, Betrixaban, Carbamazepine, Cyclosporin, Dabigatran, Digoxin, Edoxaban, Everolimus, Fluindione, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Rivaroxaban, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin, and Warfarin</b>.</p><p>During the next five years, the TDM market will undergo significant transformation. These changes will be caused ...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-228989"><span class="price">$950.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 13 Jun 2023 10:36:10 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Singapore Therapeutic Drug Monitoring (TDM) Market Assessment for 28 Assays--Supplier Shares and Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers]]></title>
      <link>https://www.leadingmarketresearch.com/singapore-therapeutic-drug-monitoring-market</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p>This unique report from LeadingMarketResearch.com provides information and analysis <b>not available from any other published source</b>.</p><p>The report is available by section, and can be customized to specific information needs and budget.</p><p>This new report from LeadingMarketResearch.com provides a comprehensive analysis of the therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.</p><p>The report provides test volume and sales forecasts by market segment for the following assays:</p><p><b>Amikacin, Apixaban, Argatroban, Betrixaban, Carbamazepine, Cyclosporin, Dabigatran, Digoxin, Edoxaban, Everolimus, Fluindione, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Rivaroxaban, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin, and Warfarin</b>.</p><p>During the next five years, the TDM market will undergo significant transformation. These changes will be caused by conv...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-229069"><span class="price">$650.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 13 Jun 2023 10:36:10 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Portugal Therapeutic Drug Monitoring (TDM) Market Assessment for 28 Assays--Supplier Shares and Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers]]></title>
      <link>https://www.leadingmarketresearch.com/portugal-therapeutic-drug-monitoring-market</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p>This unique report from LeadingMarketResearch.com provides information and analysis <b>not available from any other published source</b>.</p><p>The report is available by section, and can be customized to specific information needs and budget.</p><p>This new report from LeadingMarketResearch.com provides a comprehensive analysis of the therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.</p><p>The report provides test volume and sales forecasts by market segment for the following assays:</p><p><b>Amikacin, Apixaban, Argatroban, Betrixaban, Carbamazepine, Cyclosporin, Dabigatran, Digoxin, Edoxaban, Everolimus, Fluindione, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Rivaroxaban, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin, and Warfarin</b>.</p><p>During the next five years, the TDM market will undergo significant transformation. These changes will be caused by conv...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-229062"><span class="price">$650.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 13 Jun 2023 10:36:10 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Philippines Therapeutic Drug Monitoring (TDM) Market Assessment for 28 Assays--Supplier Shares and Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers]]></title>
      <link>https://www.leadingmarketresearch.com/philippines-therapeutic-drug-monitoring-market</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p>This unique report from LeadingMarketResearch.com provides information and analysis <b>not available from any other published source</b>.</p><p>The report is available by section, and can be customized to specific information needs and budget.</p><p>This new report from LeadingMarketResearch.com provides a comprehensive analysis of the therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.</p><p>The report provides test volume and sales forecasts by market segment for the following assays:</p><p><b>Amikacin, Apixaban, Argatroban, Betrixaban, Carbamazepine, Cyclosporin, Dabigatran, Digoxin, Edoxaban, Everolimus, Fluindione, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Rivaroxaban, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin, and Warfarin</b>.</p><p>During the next five years, the TDM market will undergo significant transformation. These changes will be caused by conv...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-229060"><span class="price">$650.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 13 Jun 2023 10:36:10 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[France Therapeutic Drug Monitoring (TDM) Market Assessment for 28 Assays--Supplier Shares and Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers]]></title>
      <link>https://www.leadingmarketresearch.com/france-therapeutic-drug-monitoring-market</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p>This unique report from LeadingMarketResearch.com provides information and analysis <b>not available from any other published source</b>.</p><p>The report is available by section, and can be customized to specific information needs and budget.</p><p>This new report from LeadingMarketResearch.com provides a comprehensive analysis of the French therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.</p><p>The report provides test volume and sales forecasts by market segment for the following assays:</p><p><b>Amikacin, Apixaban, Argatroban, Betrixaban, Carbamazepine, Cyclosporin, Dabigatran, Digoxin, Edoxaban, Everolimus, Fluindione, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Rivaroxaban, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin, and Warfarin</b>.</p><p>During the next five years, the TDM market will undergo significant transformation. These changes will be caused ...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-228986"><span class="price">$950.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 13 Jun 2023 10:36:10 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[2023-2027 World Therapeutic Drug Monitoring (TDM) Market Assessment for 28 Assays in 100 Countries--2022 Supplier Shares and 2022-2027 Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation & Opportunities]]></title>
      <link>https://www.leadingmarketresearch.com/world-therapeutic-drug-monitoring-tdm-market-assessment</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p>This unique report from LeadingMarketResearch.com provides information and analysis <b>not available from any other published source</b>.</p><p>The report is available by geographic region, country, section, and can be customized to specific information needs and budget.</p><p>This new report provides analysis of the global therapeutic drug monitoring testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.</p><p>The report provides test volume and sales forecasts by country and market segment for the following assays:</p><p><b>Amikacin, Apixaban, Argatroban, Betrixaban, Carbamazepine, Cyclosporin, Dabigatran, Digoxin, Edoxaban, Everolimus, Fluindione, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Rivaroxaban, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin, and Warfarin</b>.</p><p>During the next decade, the TDM market will undergo significant transformation. These changes will be...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-229207"><span class="price">$2,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 21 Jun 2023 13:57:37 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[2023 Europe Therapeutic Drug Monitoring (TDM) Market Assessment for 28 Assays in France, Germany, Italy, Spain, UK--2022 Supplier Shares and 2022-2027 Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation ]]></title>
      <link>https://www.leadingmarketresearch.com/europe-therapeutic-drug-monitoring-market-230038</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p>This unique report from LeadingMarketResearch.com provides information and analysis <b>not available from any other published source</b>.</p><p>The report is available by country, section, and can be customized to specific information needs and budget.</p><p>This new report from LeadingMarketResearch provides a comprehensive analysis of the European therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.</p><p>The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Apixaban, Argatroban, Betrixaban, Carbamazepine, Cyclosporin, Dabigatran, Digoxin, Edoxaban, Everolimus, Fluindione, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Rivaroxaban, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin, and Warfarin.</p><p>During the next five years, the TDM market will undergo significant transformation. These changes will be c...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-228985"><span class="price">$1,850.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 13 Jun 2023 10:36:10 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[2023 World Therapeutic Drug Monitoring (TDM) Market Assessment for 28 Assays in 100 Countries--2022 Supplier Shares and 2022-2027 Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation, Opportunities]]></title>
      <link>https://www.leadingmarketresearch.com/world-therapeutic-drug-monitoring-market</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p>This unique report from LeadingMarketResearch.com provides information and analysis <b>not available from any other published source</b>.</p><p>The report is available by geographic region, country, section, and can be customized to specific information needs and budget.</p><p>This new report provides analysis of the global therapeutic drug monitoring testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.</p><p>The report provides test volume and sales forecasts by country and market segment for the following assays:</p><p><b>Amikacin, Apixaban, Argatroban, Betrixaban, Carbamazepine, Cyclosporin, Dabigatran, Digoxin, Edoxaban, Everolimus, Fluindione, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Rivaroxaban, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin, and Warfarin</b>.</p><p>During the next decade, the TDM market will undergo significant transformation. These changes will be...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-228977"><span class="price">$7,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 13 Jun 2023 10:36:10 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[2023 Asia-Pacific Therapeutic Drug Monitoring (TDM) Market Assessment for 28 Assays in 18 Countries--2022 Supplier Shares and 2022-2027 Segment Forecasts by Test and Country, Competitive Intelligence, Technologies, Instrumentation, Opportunitinities]]></title>
      <link>https://www.leadingmarketresearch.com/asia-pacific-therapeutic-drug-monitoring-market</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p>This unique report from LeadingMarketResearch.com provides information and analysis <b>not available from any other published source</b>.</p><p>The report is available by country, section, and can be customized to specific information needs and budget.</p><p>This new report from LeadingMarketResearch provides a comprehensive analysis of the Asia-Pacific therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.</p><p>The report provides test volume and sales forecasts by country and market segment for the following assays:</p><p><b>Amikacin, Apixaban, Argatroban, Betrixaban, Carbamazepine, Cyclosporin, Dabigatran, Digoxin, Edoxaban, Everolimus, Fluindione, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Rivaroxaban, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin, and Warfarin</b>.</p><p>During the next five years, the TDM market will undergo significant transformation. These ...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-228979"><span class="price">$3,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 13 Jun 2023 10:36:10 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[2023 Germany Therapeutic Drug Monitoring (TDM) Market Assessment for 28 Assays--2022 Supplier Shares and 2022-2027 Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers]]></title>
      <link>https://www.leadingmarketresearch.com/germany-therapeutic-drug-monitoring-market</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p>This unique report from LeadingMarketResearch.com provides information and analysis <b>not available from any other published source</b>.</p><p>The report is available by section, and can be customized to specific information needs and budget.</p><p>This new report from LeadingMarketResearch.com provides a comprehensive analysis of the French therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.</p><p>The report provides test volume and sales forecasts by market segment for the following assays:</p><p><b>Amikacin, Apixaban, Argatroban, Betrixaban, Carbamazepine, Cyclosporin, Dabigatran, Digoxin, Edoxaban, Everolimus, Fluindione, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Rivaroxaban, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin, and Warfarin</b>.</p><p>During the next five years, the TDM market will undergo significant transformation. These changes will be caused ...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-228987"><span class="price">$950.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 13 Jun 2023 10:36:10 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[2023 Italy Therapeutic Drug Monitoring (TDM) Market Assessment for 28 Assays--2022 Supplier Shares and 2022-2027 Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers]]></title>
      <link>https://www.leadingmarketresearch.com/italy-therapeutic-drug-monitoring-market</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p>This unique report from LeadingMarketResearch.com provides information and analysis <b>not available from any other published source</b>.</p><p>The report is available by section, and can be customized to specific information needs and budget.</p><p>This new report from LeadingMarketResearch.com provides a comprehensive analysis of the French therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.</p><p>The report provides test volume and sales forecasts by market segment for the following assays:</p><p><b>Amikacin, Apixaban, Argatroban, Betrixaban, Carbamazepine, Cyclosporin, Dabigatran, Digoxin, Edoxaban, Everolimus, Fluindione, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Rivaroxaban, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin, and Warfarin</b>.</p><p>During the next five years, the TDM market will undergo significant transformation. These changes will be caused ...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-228988"><span class="price">$950.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 13 Jun 2023 10:36:10 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[2023 Spain Therapeutic Drug Monitoring (TDM) Market Assessment for 28 Assays--2022 Supplier Shares and 2022-2027 Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers]]></title>
      <link>https://www.leadingmarketresearch.com/spain-therapeutic-drug-monitoring-market</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p>This unique report from LeadingMarketResearch.com provides information and analysis <b>not available from any other published source</b>.</p><p>The report is available by section, and can be customized to specific information needs and budget.</p><p>This new report from LeadingMarketResearch.com provides a comprehensive analysis of the French therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.</p><p>The report provides test volume and sales forecasts by market segment for the following assays:</p><p><b>Amikacin, Apixaban, Argatroban, Betrixaban, Carbamazepine, Cyclosporin, Dabigatran, Digoxin, Edoxaban, Everolimus, Fluindione, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Rivaroxaban, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin, and Warfarin</b>.</p><p>During the next five years, the TDM market will undergo significant transformation. These changes will be caused ...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-228990"><span class="price">$950.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 13 Jun 2023 10:36:10 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[2023 UK Therapeutic Drug Monitoring (TDM) Market Assessment for 28 Assays--2022 Supplier Shares and 2022-2027 Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers]]></title>
      <link>https://www.leadingmarketresearch.com/uk-therapeutic-drug-monitoring-market</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p>This unique report from LeadingMarketResearch.com provides information and analysis <b>not available from any other published source</b>.</p><p>The report is available by section, and can be customized to specific information needs and budget.</p><p>This new report from LeadingMarketResearch.com provides a comprehensive analysis of the French therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.</p><p>The report provides test volume and sales forecasts by market segment for the following assays:</p><p><b>Amikacin, Apixaban, Argatroban, Betrixaban, Carbamazepine, Cyclosporin, Dabigatran, Digoxin, Edoxaban, Everolimus, Fluindione, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Rivaroxaban, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin, and Warfarin</b>.</p><p>During the next five years, the TDM market will undergo significant transformation. These changes will be caused ...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-228991"><span class="price">$950.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 13 Jun 2023 10:36:10 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[2023 Albania Therapeutic Drug Monitoring (TDM) Market Assessment for 28 Assays--2022 Supplier Shares and 2022-2027 Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers]]></title>
      <link>https://www.leadingmarketresearch.com/albania-therapeutic-drug-monitoring-market</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p>This unique report from LeadingMarketResearch.com provides information and analysis <b>not available from any other published source</b>.</p><p>The report is available by section, and can be customized to specific information needs and budget.</p><p>This new report from LeadingMarketResearch.com provides a comprehensive analysis of the therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.</p><p>The report provides test volume and sales forecasts by market segment for the following assays:</p><p><b>Amikacin, Apixaban, Argatroban, Betrixaban, Carbamazepine, Cyclosporin, Dabigatran, Digoxin, Edoxaban, Everolimus, Fluindione, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Rivaroxaban, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin, and Warfarin</b>.</p><p>During the next five years, the TDM market will undergo significant transformation. These changes will be caused by conv...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-228993"><span class="price">$650.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 13 Jun 2023 10:36:10 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[2023 Austria Therapeutic Drug Monitoring (TDM) Market Assessment for 28 Assays--2022 Supplier Shares and 2022-2027 Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers]]></title>
      <link>https://www.leadingmarketresearch.com/austria-therapeutic-drug-monitoring-market</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p>This unique report from LeadingMarketResearch.com provides information and analysis <b>not available from any other published source</b>.</p><p>The report is available by section, and can be customized to specific information needs and budget.</p><p>This new report from LeadingMarketResearch.com provides a comprehensive analysis of the therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.</p><p>The report provides test volume and sales forecasts by market segment for the following assays:</p><p><b>Amikacin, Apixaban, Argatroban, Betrixaban, Carbamazepine, Cyclosporin, Dabigatran, Digoxin, Edoxaban, Everolimus, Fluindione, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Rivaroxaban, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin, and Warfarin</b>.</p><p>During the next five years, the TDM market will undergo significant transformation. These changes will be caused by conv...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-228997"><span class="price">$650.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 13 Jun 2023 10:36:10 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[2023 Belarus Therapeutic Drug Monitoring (TDM) Market Assessment for 28 Assays--2022 Supplier Shares and 2022-2027 Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers]]></title>
      <link>https://www.leadingmarketresearch.com/belarus-therapeutic-drug-monitoring-market</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p>This unique report from LeadingMarketResearch.com provides information and analysis <b>not available from any other published source</b>.</p><p>The report is available by section, and can be customized to specific information needs and budget.</p><p>This new report from LeadingMarketResearch.com provides a comprehensive analysis of the therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.</p><p>The report provides test volume and sales forecasts by market segment for the following assays:</p><p><b>Amikacin, Apixaban, Argatroban, Betrixaban, Carbamazepine, Cyclosporin, Dabigatran, Digoxin, Edoxaban, Everolimus, Fluindione, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Rivaroxaban, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin, and Warfarin</b>.</p><p>During the next five years, the TDM market will undergo significant transformation. These changes will be caused by conv...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-229000"><span class="price">$650.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 13 Jun 2023 10:36:10 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[2023 Belgium Therapeutic Drug Monitoring (TDM) Market Assessment for 28 Assays--2022 Supplier Shares and 2022-2027 Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers]]></title>
      <link>https://www.leadingmarketresearch.com/belgium-therapeutic-drug-monitoring-market</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p>This unique report from LeadingMarketResearch.com provides information and analysis <b>not available from any other published source</b>.</p><p>The report is available by section, and can be customized to specific information needs and budget.</p><p>This new report from LeadingMarketResearch.com provides a comprehensive analysis of the therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.</p><p>The report provides test volume and sales forecasts by market segment for the following assays:</p><p><b>Amikacin, Apixaban, Argatroban, Betrixaban, Carbamazepine, Cyclosporin, Dabigatran, Digoxin, Edoxaban, Everolimus, Fluindione, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Rivaroxaban, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin, and Warfarin</b>.</p><p>During the next five years, the TDM market will undergo significant transformation. These changes will be caused by conv...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-229001"><span class="price">$650.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 13 Jun 2023 10:36:10 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[2023 Argentina Therapeutic Drug Monitoring (TDM) Market Assessment for 28 Assays--2022 Supplier Shares and 2022-2027 Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers]]></title>
      <link>https://www.leadingmarketresearch.com/argentina-therapeutic-drug-monitoring-market</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p>This unique report from LeadingMarketResearch.com provides information and analysis <b>not available from any other published source</b>.</p><p>The report is available by section, and can be customized to specific information needs and budget.</p><p>This new report from LeadingMarketResearch.com provides a comprehensive analysis of the therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.</p><p>The report provides test volume and sales forecasts by market segment for the following assays:</p><p><b>Amikacin, Apixaban, Argatroban, Betrixaban, Carbamazepine, Cyclosporin, Dabigatran, Digoxin, Edoxaban, Everolimus, Fluindione, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Rivaroxaban, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin, and Warfarin</b>.</p><p>During the next five years, the TDM market will undergo significant transformation. These changes will be caused by conv...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-228995"><span class="price">$650.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 13 Jun 2023 10:36:10 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[2023 Bolivia Therapeutic Drug Monitoring (TDM) Market Assessment for 28 Assays--2022 Supplier Shares and 2022-2027 Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers]]></title>
      <link>https://www.leadingmarketresearch.com/bolivia-therapeutic-drug-monitoring-market</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p>This unique report from LeadingMarketResearch.com provides information and analysis <b>not available from any other published source</b>.</p><p>The report is available by section, and can be customized to specific information needs and budget.</p><p>This new report from LeadingMarketResearch.com provides a comprehensive analysis of the therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.</p><p>The report provides test volume and sales forecasts by market segment for the following assays:</p><p><b>Amikacin, Apixaban, Argatroban, Betrixaban, Carbamazepine, Cyclosporin, Dabigatran, Digoxin, Edoxaban, Everolimus, Fluindione, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Rivaroxaban, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin, and Warfarin</b>.</p><p>During the next five years, the TDM market will undergo significant transformation. These changes will be caused by conv...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-229002"><span class="price">$650.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 13 Jun 2023 10:36:10 +0000</pubDate>
    </item>
  </channel>
</rss>
